• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肾盂十二指肠瘘并发于一名被诊断为肌层浸润性膀胱癌患者的新辅助化疗过程中。

Pyeloduodenal fistula complicating neoadjuvant chemotherapy in a patient diagnosed with muscle invasive bladder cancer.

作者信息

Alanee Shaheen

机构信息

Vattikuti Urology Institute, Detroit, MI, USA.

出版信息

Urol Case Rep. 2019 Jun 6;26:100931. doi: 10.1016/j.eucr.2019.100931. eCollection 2019 Sep.

DOI:10.1016/j.eucr.2019.100931
PMID:31297326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6597529/
Abstract

A 72-year old male presented with muscle invasive bladder cancer was counseled on the standard of care neoadjuvant chemotherapy and he started treatment. He then presented with anemia, blood in the stool and gas in the right renal pelvis and was diagnosed with Pyeloduodenal fistula. The fistula was treated with clipping by gastroenterology and the bladder tumor treated with robotic partial cystectomy.

摘要

一名72岁男性因肌肉浸润性膀胱癌前来就诊，接受了新辅助化疗的标准治疗方案并开始治疗。随后，他出现贫血、便血以及右肾盂积气，被诊断为肾盂十二指肠瘘。瘘管由胃肠病学专家进行夹闭治疗，膀胱肿瘤则采用机器人辅助部分膀胱切除术进行治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a50/6597529/057dcfc9aa11/egi10RSWC6C6B5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a50/6597529/8ec12de0bda3/egi10F4C5X6F0P.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a50/6597529/4e3b8d8fe48b/egi10JM0PQS91R.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a50/6597529/057dcfc9aa11/egi10RSWC6C6B5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a50/6597529/8ec12de0bda3/egi10F4C5X6F0P.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a50/6597529/4e3b8d8fe48b/egi10JM0PQS91R.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a50/6597529/057dcfc9aa11/egi10RSWC6C6B5.jpg

相似文献

1
Pyeloduodenal fistula complicating neoadjuvant chemotherapy in a patient diagnosed with muscle invasive bladder cancer.肾盂十二指肠瘘并发于一名被诊断为肌层浸润性膀胱癌患者的新辅助化疗过程中。
Urol Case Rep. 2019 Jun 6;26:100931. doi: 10.1016/j.eucr.2019.100931. eCollection 2019 Sep.
2
[Primary adenocarcinoma of the renal pelvis with a pyeloduodenal fistula: a case report].
Hinyokika Kiyo. 2001 Jun;47(6):421-3.
3
A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder Cancer.从诊断到新辅助化疗再到根治性膀胱切除术的时间对肌层浸润性膀胱癌患者生存影响的回顾性分析
J Urol. 2016 Apr;195(4 Pt 1):880-5. doi: 10.1016/j.juro.2015.11.024. Epub 2015 Nov 18.
4
[Pyeloduodenal Fistula Caused by Renal Calculi].
Korean J Gastroenterol. 2018 Apr 25;71(4):229-233. doi: 10.4166/kjg.2018.71.4.229.
5
Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.回顾性分析两周期 M-VAC 新辅助化疗后行根治性膀胱切除术治疗肌层浸润性膀胱癌的疗效。
Anticancer Res. 2013 Oct;33(10):4497-503.
6
History of Non-Muscle-Invasive Bladder Cancer May Have a Worse Prognostic Impact in cT2-4aN0M0 Bladder Cancer Patients Treated With Radical Cystectomy.肌层浸润性膀胱癌病史可能对接受根治性膀胱切除术治疗的 cT2-4aN0M0 膀胱癌患者的预后产生更差的影响。
Clin Genitourin Cancer. 2018 Oct;16(5):e969-e976. doi: 10.1016/j.clgc.2018.04.004. Epub 2018 Apr 28.
7
The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study.新辅助化疗对根治性膀胱切除术治疗膀胱癌患者围手术期结局的影响：一项基于人群的研究。
Eur Urol. 2014 Sep;66(3):561-8. doi: 10.1016/j.eururo.2014.01.014. Epub 2014 Jan 24.
8
Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer.接受新辅助化疗后拒绝膀胱切除术的肌层浸润性膀胱癌患者的结局
Eur Urol. 2008 Jul;54(1):126-32. doi: 10.1016/j.eururo.2007.12.031. Epub 2007 Dec 27.
9
Severe anemia and melena caused by pyeloduodenal fistula due to renal stone-associated squamous cell carcinoma.因肾结石相关鳞状细胞癌导致肾盂十二指肠瘘引起严重贫血和黑便。
Pak J Med Sci. 2014 Mar;30(2):443-5.
10
[Neoadjuvant intra-arterial chemotherapy followed by partial cystectomy for invasive bladder cancer].[新辅助动脉内化疗后行部分膀胱切除术治疗浸润性膀胱癌]
Hinyokika Kiyo. 1992 Feb;38(2):155-9.

引用本文的文献

1
Pyeloduodenal fistula: a review of the current literature.肾盂十二指肠瘘：当前文献综述
Int Urol Nephrol. 2025 May;57(5):1357-1363. doi: 10.1007/s11255-024-04327-8. Epub 2024 Dec 17.

本文引用的文献

1
Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors.接受免疫检查点抑制剂治疗的患者的上消化道症状及相关内镜和组织学特征
Scand J Gastroenterol. 2019 May;54(5):538-545. doi: 10.1080/00365521.2019.1594356. Epub 2019 May 13.
2
Dietary ω -3 polyunsaturated fatty acid DHA: a potential adjuvant in the treatment of cancer.膳食 ω-3 多不饱和脂肪酸 DHA：癌症治疗的潜在辅助剂。
Biomed Res Int. 2013;2013:310186. doi: 10.1155/2013/310186. Epub 2013 May 23.
3
Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies.
癌症化疗引起的腹泻和便秘：损伤机制及预防策略。
Support Care Cancer. 2006 Sep;14(9):890-900. doi: 10.1007/s00520-006-0040-y. Epub 2006 Apr 8.
4
Renoduodenal fistula in a patient with chronic nephrostomy drainage: a case report.一名慢性肾造瘘引流患者的肾十二指肠瘘：病例报告
J Urol. 1991 Sep;146(3):835-7. doi: 10.1016/s0022-5347(17)37935-1.